Possibilities of improving the parameters of hyperthermia in regional isolated limb perfusion using epidural bupivacaine and accurate temperature measurement of the three layers of limb tissue
暂无分享,去创建一个
[1] P. Schlag,et al. Treatment of melanoma in-transit metastases confined to the limb , 1996, Acta Chirurgica Austriaca.
[2] P. Schlag,et al. Intracompartmental pressure during hyperthermic isolated limb perfusion for melanoma and sarcoma , 2006, Annals of Surgical Oncology.
[3] R. Smalley,et al. Hyperthermic perfusion with chemotherapy for melanoma of the extremities , 1989, World Journal of Surgery.
[4] E. Krementz,et al. The use of regional chemotherapy in the management of malignant melanoma , 1979, World Journal of Surgery.
[5] S. Mocellin,et al. Hyperthermic Isolated Limb Perfusion With Low-Dose Tumor Necrosis Factor-α and Melphalan for Bulky In-Transit Melanoma Metastases , 2004, Annals of Surgical Oncology.
[6] A. Eggermont,et al. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. , 2003, The Lancet. Oncology.
[7] L. Jost. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] D. Tyler,et al. Long-Term Survival in 2,505 Patients With Melanoma With Regional Lymph Node Metastasis , 2002, Annals of surgery.
[9] H. Hoekstra,et al. Continuous Leakage Measurement During Hyperthermic Isolated Limb Perfusion , 2001, Annals of Surgical Oncology.
[10] J. Thompson,et al. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies , 2001, British Journal of Cancer.
[11] A. Eggermont,et al. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion , 2000, British Journal of Cancer.
[12] A. Eggermont,et al. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study. , 1999, Melanoma research.
[13] A. Eggermont,et al. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, a , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] M. Inbar,et al. High dose tumor necrosis factor‐α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation , 1997, Cancer.
[15] P. Schlag,et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. , 1996, Annals of surgery.
[16] M. Papa,et al. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities. , 1996, American journal of surgery.
[17] B. Vrouenraets,et al. Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma , 1995, Melanoma research.
[18] D. Fraker,et al. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor. , 1995, The cancer journal from Scientific American.
[19] R. Mirimanoff,et al. Regional therapy of melanoma. , 1993, European journal of cancer.
[20] N. Renard,et al. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] J. Thomas,et al. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb , 1990, The British journal of surgery.
[22] B. Kroon,et al. Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future. , 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[23] N. Cascinelli,et al. Hyperthermic antiblastic perfusion in extracorporeal circulation: surgical technique and results in the treatment of extremities tumor , 1986 .
[24] B. Mondovì,et al. Selective Heat Sensitivity of Cancer Cells , 1977, Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer.
[25] C. Heidelberger,et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies , 1967 .
[26] J. Stehlin,et al. Regional chemotherapy for cancer: experiences with 116 perfusions. , 1960, Annals of surgery.
[27] R. F. Ryan,et al. Treatment of melanoma by isolation-perfusion technique. , 1959, Journal of the American Medical Association.